Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNA
Ontology highlight
ABSTRACT: Silencing HoxA1 in vivo by intraductal delivery of nanoparticle-formulated siRNA reduced mammary tumor incidence by 75% , reduced cell proliferation, and prevented loss of ER and PR expression.
ORGANISM(S): Mus musculus
PROVIDER: GSE50813 | GEO | 2013/12/31
SECONDARY ACCESSION(S): PRJNA219072
REPOSITORIES: GEO
ACCESS DATA